Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Luciana da Rocha Pitta"'
Autor:
Leonardo Henrique Toehwé, Thiago da Silva Honorio, Luiz Claudio Rodrigues Pereira da Silva, Thalita Martins da Silva, Luciana da Rocha Pitta, Livia Deris Prado, Lucio Mendes Cabral, Helvécio Vinícius Antunes Rocha
Publikováno v:
Ars Pharmaceutica, Vol 62, Iss 4, Pp 358-370 (2021)
Abstract Introduction: The immediate-release solid oral products containing very soluble and permeable drugs are candidates for the biowaiver process. This work aims to compare in vitro, in silico, and in vivo data to establish if previously publishe
Externí odkaz:
https://doaj.org/article/5eaa577d75e54bba8fe4405c5f78aee5
Autor:
Francisco José Roma Paumgartten, Isabella Fernandes Delgado, Luciana da Rocha Pitta, Ana Cecilia Amado Xavier de Oliveira
Publikováno v:
Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia, Vol 8, Iss 2 (2020)
Introduction: So far, there is no vaccine, nor are there effective drugs to treat COVID-19, an emerging viral respiratory infection deadlier than influenza. Objective: To take a snapshot picture of planned and ongoing clinical research addressing dru
Externí odkaz:
https://doaj.org/article/7ffba210b49b46ceab8cb164ce609341
Autor:
Francisco José Roma Paumgartten, Isabella Fernandes Delgado, Luciana da Rocha Pitta, Ana Cecilia Amado Xavier de Oliveira
Publikováno v:
Cadernos de Saúde Pública, Vol 36, Iss 5
Externí odkaz:
https://doaj.org/article/f845e5b040f44868bdfb3b8ff81a4a21
Autor:
Leonardo Henrique Toehwé, Thiago da Silva Honorio, Luiz Claudio Rodrigues Pereira da Silva, Thalita Martins da Silva, Luciana da Rocha Pitta, Livia Deris Prado, Lucio Mendes Cabral, Helvécio Vinícius Antunes Rocha
Publikováno v:
Ars Pharmaceutica (Internet) v.62 n.4 2021
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Ars Pharmaceutica, Vol 62, Iss 4, Pp 358-370 (2021)
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Ars Pharmaceutica, Vol 62, Iss 4, Pp 358-370 (2021)
Introducción: Los productos orales sólidos de liberación inmediata que contienen fármacos muy solubles y permeables son candidatos para el proceso de bioexención. Este trabajo tiene como objetivo comparar datos in vitro, in silico e in vivo para
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1a4bfe251daed947ea973829b90aaa5
http://hdl.handle.net/10481/71430
http://hdl.handle.net/10481/71430
Autor:
Francisco José Roma Paumgartten, Ana Cecilia Amado Xavier de Oliveira, Luciana da Rocha Pitta, Isabella Fernandes Delgado
Publikováno v:
Cadernos de Saúde Pública, Vol 36, Iss 5
Autor:
Stanley E.R. Bilatto, Daniel S. Correa, Leandro Tasso, Maira Assis da Costa, Luciana da Rocha Pitta, Lucio Mendes Cabral, Cristiane Rodrigues Drago Hoffmeister, Cinira Fandaruff, Marcos Antonio Segatto Silva, Livia Deris Prado, Helvécio Vinícius Antunes Rocha
Publikováno v:
European Journal of Pharmaceutical Sciences. 99:310-317
Efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor (NNRTI), is part of first-line therapy for the treatment of human immunodeficiency virus type 1 infection (HIV-1/AIDS). This drug shows relatively low oral absorption and bioavailabili
Publikováno v:
Arquivos de Asmas Alergia e Imunologia. 3
Autor:
Luciana da Rocha Pitta, André Daher, Draurio Barreira, Douglas Pinto, Tereza Cristina dos Santos
Publikováno v:
Memórias do Instituto Oswaldo Cruz, Volume: 110, Issue: 4, Pages: 543-550, Published: 02 JUN 2015
Memórias do Instituto Oswaldo Cruz
Memórias do Instituto Oswaldo Cruz., Vol 110, Iss 4, Pp 543-550 (2015)
Memórias do Instituto Oswaldo Cruz
Memórias do Instituto Oswaldo Cruz., Vol 110, Iss 4, Pp 543-550 (2015)
The recommended treatment for latent tuberculosis (TB) infection in adults is a daily dose of isoniazid (INH) 300 mg for six months. In Brazil, INH was formulated as 100 mg tablets. The treatment duration and the high pill burden compromised patient